GeneDx Holdings Corp. Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
GeneDx Holdings Corp. (WGS) reported Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow
us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 · last filed 2024-02-23
- GeneDx Holdings Corp. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2023-06-30 was $0.00.
- GeneDx Holdings Corp. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- GeneDx Holdings Corp. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2022-12-31 was $0.00.
- GeneDx Holdings Corp. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2022-09-30 was -$200.00K.
- GeneDx Holdings Corp. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for fiscal 2022 was -$10.20M.
| Period end | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 3 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 6 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 9 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 12 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | -$200.00K derived: sum of 4 quarters · filed 2024-02-23 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | -$200.00K derived: sum of 3 quarters · filed 2024-02-23 | -$3.50M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$200.00K derived: sum of 2 quarters · filed 2024-02-23 | -$3.50M derived: sum of 3 quarters · filed 2024-02-23 | -$10.20M 10-K · filed 2024-02-23 | -$21.10M 10-K · filed 2023-03-16 |
| 2022-09-30 | -$200.00K 10-Q · filed 2022-11-14 | -$3.50M derived: sum of 2 quarters · filed 2022-11-14 | -$10.20M 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | -$3.30M 10-Q · filed 2022-08-15 | -$10.10M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | $6.80M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |